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The management of late preterm prelabour rupture of membranes (PPROM) is 
associated with an increased risk of neonatal prematurity related morbidity due to 
many obstetric care guidelines which favour delivery at 34 weeks or immediately 
upon diagnosis of ruptured membranes after 34 weeks gestation. However, expectant 
management of this group of patients (i.e delayed delivery) between 34+0 and 36+6 
weeks of gestation is associated with an increased risk of neonatal and maternal 
infectious morbidities.  
 
Aim of Study: 
 
The aim of this study was to evaluate the impact of the latency period on maternal 
and neonatal outcomes in late preterm prelabour rupture of membranes in a regional 
perinatal service in Cape Town, South Africa. The latency period was defined as the 
time from rupture of membranes to the time of delivery. In addition, we sought to 
investigate whether immediate induction of labour in the absence of overt signs of 
infection or fetal compromise should be prioritised in women who present with late 




This was a retrospective cohort study carried out over a period of two years in two 
secondary level hospitals of the Metro West area of Cape Town. The subjects were 
low risk HIV negative women with singleton pregnancies with ruptured membranes 
in the late preterm period. Maternal and neonatal outcomes were studied between 
two latency periods, namely short latency (< 48 hours) and long latency period (≥ 48 






Results and Conclusion: 
 
There were no significant differences in maternal and neonatal outcomes between the 
two groups of latency periods when latency was defined as the time from ruptured 
membranes to delivery. The study favoured a delayed induction thereby improving 
neonatal outcomes by decreasing the complications of prematurity. There were more 
adverse maternal outcomes, including an increase likelihood of augmentation of 
labour and more operative delivery along with its major risk, that of obstetric 
haemorrhage, were noted in the short latency period group. Therefore, a delayed 
induction policy appeared to be more appropriate.  
 
Preterm delivery places the newborn at risk of prematurity. Therefore, the risk of 
prematurity must be balanced with the risks of intrauterine infection and antepartum 
haemorrhage, the two major complications of expectant management if delayed 
induction is to be adopted. Proper monitoring of both the pregnant woman and fetus 
is essential when expectant management is carried out to avoid these adverse 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
Prelabour rupture of membranes (PROM) is defined as the rupture of the fetal 
membranes before the onset of uterine contractions. Term PROM complicates 
approximately 8% of all pregnancies.  
 
When PROM occurs before 37 completed weeks of pregnancy, it is referred to as 
preterm prelabour rupture of membranes (PPROM). PPROM complicates only 2% of 
all pregnancies but it is associated with 40% of preterm deliveries, thus resulting in 
significant neonatal morbidity and mortality.1 
 
The aetiology of PPROM is obscure. Evidence suggests that there is an association 
between ascending infection from the lower genital tract and PPROM. About one third 
of pregnancies have positive amniotic fluid cultures and studies have shown that 
bacteria have the ability to cross intact fetal membranes.2,3 Hence PPROM is 
associated with significant maternal, fetal and neonatal risks. 
 
The maternal risk associated with PPROM include subclinical chorioamnionitis 
(30%), abruptio placenta, psychosocial sequelae as a result of prolonged 
hospitalisation and uncertain neonatal prognosis and increase in operative 
intervention.4,5,6,7 
 
Prematurity is the major cause of neonatal morbidity and mortality. The major 
morbidities include respiratory distress syndrome (RDS), cerebral palsy, necrotising 











1.1 DIAGNOSIS OF PROM: 
The diagnosis of PROM should be done judiciously. The history of   passing a gush of 
fluid, feeling constantly wet and fluid draining down the legs is very common. In most 
cases, the ruptured membranes is confirmed by documenting amniotic fluid leakage 
from the cervical os with visualisation of pooling of fluid in the posterior fornix of the 
vagina on a sterile speculum examination. 
 
Other methods for the diagnosis of PROM include a combination of diagnostic tests:9   
1. Litmus paper and pH testing 
2. Nitrazine paper test 
3. Amniotic fluid crystallisation (Ferning test) 
4. Ultrasound assessment of amniotic fluid 
5. Intra-amniotic dye injection 
6.  Other methods such as:  
a. Determination of certain markers in amniotic fluid such as Alpha-feto 
Protein (AFP), Beta hCG, fetal fibronectin, lactate, creatinine and urea. 
b. Determination of Alpha-1 microglobulin by amnisure ROM 
immunoassay test.   
It must be noted that digital vaginal examination is best avoided because this may 















1.2 LITERATURE REVIEW OF THE MANAGEMENT OF PPROM: 
 
When prelabour rupture of membranes occurs at term, Hannah et al10 in the 
TERMPROM study provided good evidence for early delivery in view of a lower 
incidence of maternal infection and increased maternal satisfaction as compared with 
expectant management. 
 
Similarly, for gestation before 34 weeks, most existing guidelines recommend 
expectant management for further fetal maturation.1,8,11 
 
The American College of Obstetricians and Gynaecologists (ACOG) guidelines 
recommend induction of labour (IOL) if PPROM occurs at or beyond 34+0 weeks of 
gestation.8 The Royal College of Obstetricians and Gynaecologists (RCOG) guideline 
states that delivery should be considered at 34+0 weeks of gestation and recommends 
that women with PPROM who are managed expectantly beyond 34 weeks of gestation 
should  be counselled about the increased risk of chorioamnionitis and the presumed 
decreased risk of neonatal respiratory problems, admission for neonatal intensive care, 
and caesarean section.1  
 
The current standard of care as recommended by the Maternal Obstetric Guidelines 
for South Africa is to induce labour within 12 to 24 hours and in patients who are HIV 
positive, delivery should ideally occur within 4 hours from the time of rupture of 
membranes.11 The latter may however change with the recent National Consolidated 
Guidelines for PMTCT12 (Prevention of Mother to Child Transmission) in South 
Africa which puts emphasis on viral load monitoring every 3 months in pregnancy 
hence ensuring that pregnant women are fully suppressed at the time of labour to 
prevent mother to child transmission of HIV. 
 
Therefore, the management of PPROM between 34+0 and and 36+6 weeks still remains 





Late Preterm births constitute the group of neonates who are born between 34+0 to 36+6 
weeks. They are considered to be physiologically immature and have limited 
compensatory responses to extrauterine life. They are at risk of major complications, 
including respiratory distress, apnoea, temperature instability, sepsis, metabolic 
complications like hypoglycaemia and hyperbilirubinaemia and poor feeding.  
Furthermore, infants born during the late preterm period compared with term infants 
are at an increased risk of developing cerebral palsy due to the fact that the last six 
weeks of gestation represent a critical period of brain growth and development.13 
 
However, in PPROM, these neonatal morbidities and risks need to be balanced against 
the increased incidence of chorioamnionitis, which can be up to 30% with the 
expectant management of late preterm PPROM.10 Although there is a low incidence 
of neonatal sepsis (about 2-4%), chorioamnionitis is a known risk factor for the 
development of neurological sequelae such as cerebral palsy.14,15 
 
While immediate delivery of the fetus above 34 weeks of gestation in patients with 
PPROM may protect the neonate from infection, prolonging the pregnancy may allow 
the fetus to mature, thus reducing the risk of much more prematurity-related morbidity.  
 
In PPROM, the optimal interval for delivery occurs when the risks of immaturity are 
outweighed by the risks of pregnancy prolongation such as infection, placental 
abruption and cord accidents. 
 
A further search of the literature, including Cochrane reviews, Medline, and Pubmed, 
found very few studies done to provide evidence on the care of patients with PPROM 
between 34+0 and 36+6 weeks of gestation. The following are a few of the trials and 








PPROMEXIL (PPROM Expectant Management versus Induction of Labour) trial was 
done from January 2007 to September 2009, as a randomized controlled trial in 60 
hospitals with 536 patients in The Netherlands. The trial included non-labouring 
women with more than 24 hours of PPROM between 34+0 and 37+0 weeks of gestation 
with the main outcome being neonatal sepsis. Neonatal sepsis occurred in seven 
(2.6%) newborns of women in the IOL group and in 11 (4.1%) neonates in the 
expectant management group (relative risk [RR] 0.64; 95% confidence interval [CI] 
0.25 to 1.6). RDS was seen in 21 (7.8%, IOL) versus 17 neonates (6.3%, EM) (RR 1.3; 
95% CI 0.67 to 2.3), and a caesarean section was performed in 36 (13%, IOL) versus 
37 (14%, EM) women (RR 0.98; 95% CI 0.64 to 1.50). The risk for chorioamnionitis 
was reduced in the IOL group. No serious adverse events were reported.  
 
Because the PPROMEXIL trial was underpowered and because of a lower than 
expected incidence of neonatal sepsis, another trial was performed PPROMEXIL-2 
between December 2009 until January 2011 as a randomised controlled trial of 200 
patients in the Netherlands. The investigators found that induction of labour did not 
reduce the incidence of neonatal sepsis and therefore concluded that expectant 
management seemed to be a safe strategy with respect to neonatal sepsis (3.0% in the 
induction group versus 4.1% in the expectant group). The relative risk of neonatal 
sepsis was 0.74; 95% confidence interval, 0.17-3.2.16 
 
A randomised trial done by Mercer et al17, with 93 patients with PPROM between 32 
to 36+6 weeks of gestation who were assigned to either immediate or delayed delivery, 
showed that the incidence of respiratory distress syndrome, intraventricular 
haemorrhage and confirmed neonatal sepsis was not significantly different in the two 
groups. They however observed that expectant management had prolonged maternal 
and neonatal hospitalisation and an incidence of chorioamnionitis (27.7%) which was 
higher than the 10.9% in the induced group. They concluded that immediate induction 






Naef et al18 did a prospective study of 120 women with PPROM between 34 to 37 
weeks of gestation at the University of Mississippi and found that the expectantly 
managed group had a higher incidence of chorioamnionitis (16%) compared with the 
immediate delivery group (2%). The incidence of neonatal sepsis was 5% in the 
expectantly managed group compared to none in the immediate delivery group. The 
results were not statistically significant. 
 
Neerhof et al19 did a retrospective study examining the neonatal outcome following 
cases with PPROM between 32 to 36 weeks of gestation which showed that the 
specific gestation for reduced morbidity was 34 weeks. They showed a reduced 
incidence of respiratory distress syndrome of 22.5% and 5.8% at 33 and 34 weeks of 
gestation respectively. However, although the incidence of RDS beyond 34 weeks was 
relatively low, the condition still affected newborns at 36 weeks, with incidences of 
10.4 % and 1.5 % at 35 and 36 weeks respectively. 
 
A large international multi-centre, randomised controlled trial (PPROMT Trial) with 
1835 recruits from 65 centres in 11 countries was carried out. The PPROMT trial, 
(Preterm prelabour rupture of membranes close to term) finished in December 2013. 
The aim was to evaluate the effectiveness of early planned birth compared with 
expectant management for women with PPROM between 34+0 weeks to 36+6 weeks of 
gestation. The primary outcome was neonatal sepsis. In this trial, 924 women were 
randomised to early delivery and 915 to expectant management. Neonatal sepsis 
occurred in 23 (2%) in the immediate delivery group and in 29 (3%) of the neonates 
in the expectant management group. However, 8% of the neonates in the immediate 
delivery group had respiratory distress syndrome and 5% developed the condition in 
the expectant management group. Compared to women assigned to the immediate 
delivery group, those who were managed expectantly had higher risks of antepartum 
haemorrhage, intrapartum fever and the use of postpartum antibiotics along with a 







1.3 MANAGEMENT OF PPROM IN WESTERN CAPE SOUTH AFRICA 
 
The Maternal Obstetric Care Guidelines for South Africa (4th edition 2015), 
recommends that induction of labour should be carried out within 12-24 hours if the 
gestational age is above 34 weeks or estimated fetal weight (EFW) is above 2 kg in 
women with PPROM. The Western Cape protocols for maternal care at district 
hospitals does not stipulate immediate delivery for these patients. Thus, the Metro 
West maternal and neonatal service presents an opportunity to investigate if 
differences in maternal and neonatal outcomes exist between active and conservative 
management of late preterm PPROM.  
 
The management options, as supported by the evidence, do not clearly favour either 
expectant management or immediate delivery. There is no local data to indicate 
whether either of these methods results in a better outcome. The generally accepted 
management of confirmed PPROM above 34 weeks is to wait for 24 hours for the 
spontaneous onset of labour and then induce if it does not occur. This is based on two 
assumptions: 
1) Seventy percent of women will go into spontaneous labour within the first 24 
hours after PPROM.8,10,22 
2) Lung maturity has usually occurred by 34 weeks and after that there should be 
good fetal outcome. 
A longer latency interval with expectant management may allow time for clinical 
chorioamnionitis, which either is subclinical at the time of membrane rupture or 
develops with ascending bacterial infection subsequent to membrane rupture. 
 
Proponents of delivery at 34 weeks argue that because of the lack of significant 
neonatal benefits with the prolongation of pregnancy until 37 weeks, early delivery is 
justified to reduce the risk of chorioamnionitis and neonatal sepsis. In Australia, a 
survey was conducted in women with PPROM above 34 weeks. In the survey, 49% of 
obstetricians indicated that they would manage these patients expectantly with the 
women staying in hospital and 51% would plan to deliver these women prior to term.23  
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It would appear that the relative benefits and risks of active versus expectant 
management after PROM in late preterm is not clear and this would justify further 
research.  
 
South Africa is a low income country and has a high rate of neonatal infection in view 
of the low socioeconomic conditions which prevail among the high risk population. 
Furthermore, with the high prevalence of HIV, the incidence of chorioamnionitis and 
the risks of HIV transmission to neonates in patients with unsuppressed viral load 
could be high in cases of PPROM. The current standard of care as recommended by 
the Maternal Guidelines for South Africa is to induce labour within 12-24 hours. In 
patients who are HIV positive, delivery should occur within 4 hours from the time of 
rupture of membranes to reduce the risk of mother to child transmission of HIV. These 
patients are usually managed at level 2, regional referral hospitals with neonatal ICU 
facilities. However due to bed constraints and other operational issues, patients often 
wait longer before being induced and thus the latency period which is defined as the 
time between rupture of membranes and delivery may have an impact on both maternal 
and neonatal outcomes.  
 
 In view of the above, several questions remain:  
• Can we manage patients with PPROM near term expectantly to reduce the risk 
of prematurity-related comorbidities?   
• Should we offer an early delivery to reduce the risk of chorioamnionitis, 
neonatal and maternal sepsis?  
• What is the optimal delivery time in patients with late preterm prelabour 










CHAPTER 2: METHODS 
 
2.1 Aim of the study: 
 
The aim of this study was to determine whether delayed delivery compared with early 
planned delivery was associated with more neonatal and maternal morbidities in 




For the purpose of the study, a latency period of 48 hours was taken to separate patients 
into two groups namely early delivery group (latency period < 48 hours) and 
delayed/late delivery group (latency period ≥ 48 hours). We anticipated that there 
would be a higher rate of composite neonatal and maternal infectious morbidities in 
the late delivery group. We further anticipated less neonatal prematurity related 
morbidities in the late delivery group.  
 
The null hypothesis and sample size calculation was based on the primary outcomes 
that there will be no differences in the rate of maternal and neonatal infectious 
morbidities and prematurity related morbidities between the two groups of patients 
with PPROM at 34+0 to 36+6 weeks of gestation that are delivered before and after 48 
hours. 
 
2.3 Study Design: 
 
The study was a retrospective observational cohort study to assess the impact of early 
delivery (< 48 hours) versus late delivery (≥ 48 hours) on the maternal and neonatal 
outcomes for women with Preterm PROM between 34+0 to 36+6 weeks of gestation. 
The cut-off point of 48 hours was taken to differentiate the two groups of patients 
based on the Maternal Obstetric Care Guidelines of South Africa that induction of 





2.4 Study Setting: 
 
The study was conducted at Mowbray Maternity Hospital (MMH) and New Somerset 
Hospital (NSH). These are urban Metro West level 2 regional referral hospitals. Both 
hospitals are public maternity hospitals. These secondary hospitals receive patients 
from primary care Midwife Obstetric Units (MOU) and from the surrounding 
residential areas. The MOUs include Gugulethu (GMOU), Hanover Park (HPMOU), 
Retreat (RMOU), Mitchell’s Plain MOU (MPMOU), Vanguard MOU (VMOU), as 
well as Westfleur and False Bay hospitals.  
 
2.5 Patient selection: 
 
The patient population consisted mostly of the lower to middle socio-economic status 
with patients of mixed ethnicity and a large migrant population. The patients were 
selected according to a set of inclusion and exclusion criteria as shown in the table 
below. The names and folder numbers of eligible subjects were identified in the 
admission suite and antenatal ward registers of Mowbray Maternity and New Somerset 
Hospitals. The patient folders were then retrieved from the appropriate records 
department and screened for eligibility.  
 
As per the Western Cape protocol, any pregnant woman with PPROM below 37 weeks 
is referred to a district or secondary level hospital for further management. Therefore, 













Table 2.1: Inclusion and Exclusion Criteria 
 
Inclusion criteria Exclusion criteria 
Pregnant woman between 34+0 to 
36+6 weeks gestation with a live fetus 
HIV positive patients 
Singleton pregnancy with no major 
congenital anomalies 
Fetal demise 
 Non reassuring CTG on admission 
 Meconium Stained Liquor with an 
abnormal CTG 
 Patients in established labour on admission 
 Patients with clinical evidence of 
chorioamnionitis on admission 
 Antepartum haemorrhage on admission 
 Abnormal presentation 
 Active Genital herpes 
 Placenta praevia 
 Multiple pregnancy 
 
• Since the study was carried out in a low risk population, patients with maternal 
medical diseases were excluded. Furthermore the study was carried out in secondary 
level hospitals and most patients with medical diseases are managed at our tertiary 













The outcomes of the study were divided into primary and secondary maternal and 
neonatal outcomes. 
 
2.61 Primary outcomes 
The primary outcome associated with the latency period of 48 hours were described 
as follows: 
• Composite Neonatal Infectious Morbidity 
• Composite Neonatal Prematurity Morbidity 
• Composite Maternal Infectious Morbidity 
 
1) Composite Neonatal Infectious Morbidity:  
This was defined as any one of the following: 
a. A diagnosis of sepsis (A positive blood or CSF culture with an identified 
organism) 
b. Pneumonia 
c.  Necrotising Enterocolitis  
The clinical signs of neonatal sepsis include respiratory distress, apnoea, lethargy, 
abnormal level of consciousness, circulatory compromise needing support, poor 
feeding and/or temperature instability. 
 
2) Composite Neonatal Prematurity Morbidity: 
This was defined as a diagnosis of any one of moderate or severe Respiratory distress 
syndrome, Bronchopulmonary Pulmonary Dysplasia, Intraventricular Haemorrhage, 
Periventricular leukomalacia or Retinopathy of Prematurity. 
 
3) Composite Maternal Infectious Morbidity:  
This was defined as a diagnosis of any puerperal sepsis which included endometritis, 




2.62 Secondary Outcomes: 
 
These were grouped into secondary neonatal and maternal outcomes as described in 
detail in Appendix 2. 
 









Apgar Scores at 1 and 5 
minutes intervals 
Intrapartum fever Puerperal sepsis 
Birth Weight Chorioamnionitis Hysterectomy 
Metabolic complications Antepartum 
haemorrhage 
Antibiotic requirement 
Admission to NICU or 
high care unit 
Spontaneous onset of 
labour 
Duration of maternal 
admission 
Duration of neonatal 
admission 
Augmentation of labour  
 Mode of delivery  
 
2.7 Data Collection: 
 
A data collection sheet (Appendix 1) was designed to capture baseline demographic 
and medical information as well as the method of delivery. 
The data collection consisted of two parts. The first part included the demographic 
details, booking details of the index pregnancy, and important clinical information 
during the antenatal period. The second part included maternal and neonatal 
outcomes. Data from the data collection sheets were transcribed into an MS-Excel 
spreadsheet. All patient identification information was removed from the 
spreadsheet, and the computer had a lock and access code which was known only to 
the Principal Investigator (PI). 
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2.8 Statistical Methods for Data Analysis: 
 
This study was designed to demonstrate that managing PPROM patients between 34+0 
to 36+6 weeks with early delivery defined as a latency period < 48 hours would result 
in less neonatal and maternal infectious morbidities compared to those delivered after 
48 hours. We estimated   that the risk of adverse outcomes in the early delivery group 
would be 4% and that in the late delivery group 20%.  
 
As per the Maternal Obstetric Care Guidelines for South Africa, we expected that 75% 
of the patients would have been delivered before 48 hours and that 25% delivered after 
48 hours.23 We calculated a sample size of 122 patients with 80% power and a 
significance level of p = 0.05.  
 
Demographic data were presented in tabular and descriptive formats. Data were 
presented in descriptive form with appropriate statistical inference as applicable. 
Continuous numerical data was analysed using the t-test. Non parametric numerical 
data was analysed using the Wilcoxon sum-rank test. Categorical data was analysed 
statistically using Chi-square test, with Friedman test being used for any data with 
fewer than 5 events in any given category. Statistical analysis was performed using 
Stata® version 13.  
 
2.9 Ethical considerations: 
 
Following approval by the Departmental Research Committee, the study protocol 
was submitted  to and approved by the Human Ethics Research Committee (HREC) 
of the University of Cape Town (Appendix 3). Informed consent was not required for 
the study since all data were retrieved by folder review. All information was kept 
confidential. Further approval was obtained from the facility based research 







CHAPTER 3: RESULTS 
 
The folders of 122 patients were retrieved from Mowbray Maternity and New 
Somerset Hospitals for the study of the effect of latency period on maternal and 
neonatal outcomes in women who had ruptured membranes between 34+0 to 36+6 
weeks of gestation. Latency period was defined as the duration from the time of 
rupture of membranes until the time of delivery.  
 
There were two latency periods, a shorter latency period which was before 48 hours 
and a longer which was at or beyond 48 hours. 
 
All of these patients delivered between January 2014 to June 2016. They were all 
low risk patients and there were no other indications for induction of labour. In 
addition, the patients were all HIV negative. 
 
 






























1.1 Demographic Details: 
 
Table 3.1: Table of Demographics 
 
 MINIMUM MAXIMUM MEAN/MEDIAN 
AGE 15 41 25.8 
GRAVIDA 1 6 2 
PARITY 0 4 1 
SOCIOECONOMIC   
STATUS n(%) 
LOW AVERAGE UNKNOWN 
60(49.2) 57(46.7) 5(4.1) 
ETHNICITY n(%) BLACK COLOURED WHITE 
30(24.6) 80(65.6) 12(9.8) 
 
3.11 Maternal Age/ Gravidity/Parity 
 
The minimum age in the study was 15 and the maximum age was 41 with a mean 
age of 25.8 years old. 
Gravida is defined as the number of times a woman has been pregnant regardless of 
whether these pregnancies were carried to term. In the study the minimum gravidity 
was 1 and the maximum was 6 with a median gravidity of 2. 
Parity is defined as the number of times a woman has given birth to a viable fetus 
that is above 28 weeks of gestation. The median parity was 1. 
Table 3.2: Comparison of Demographics between the two latency periods 
 
 LATENCY PERIOD   < 
48 HOURS 
(n=81) 






26.0 25.4 P=0.61 
GRAVIDA 2 2 P=0.77 
PARITY 1 1 P=0.56 
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Most women in the study were between gravida 1 to gravida 3 (78.7%). This was 
consistent between the short and long latency groups. In both groups most patients 
were either nulliparous or primiparous (71.3%). 
 
There were 81 patients in the short latency group and 41 patients in the long latency 
group. There was no statistical difference in the means and distribution of maternal 
ages between the two groups, short latency period and long latency period (p=0.61).  
 
3.12 Socioeconomic Status: 
Socioeconomic status was defined in terms of monthly revenue which was less than 
R2000 in low socioeconomic groups and between R2000 to R4000 in the average 
socioeconomic groups 
 
The number of patients with preterm prelabour rupture of membranes was found to 
be nearly equally distributed between low and average socioeconomic status. It 
should be noted that the study was carried out in public hospitals that provide free 
health care services. The monthly income of approximately 4% of the study 
population could not be found. 
 
3.13 Ethnicity: 
   
Out of the 122 folders that were retrieved, 65.6% of the patients were found to be 
coloured, 24.5% were black African and 9.8% were white when grouped under 
major racial categories in the Republic of South Africa. In the short latency period, 
there were   27.2% black, 63.0% coloured and 9.9% white patients. In the long 
latency period, there were 19.5% black, 70.7% coloured and 9.8% of black patients. 








Table 3.3: Comparison of ethnicity between Latency period 
 
 
 BLACK COLOURED WHITE 
LATENCY PERIOD   < 48 
HOURS 
(N=81) 
22/81 (27.2%) 51/81 (63.0%) 8/81 (9.9%) 
LATENCY PERIOD ≥ 48 
HOURS 
(n=41) 
8/41 (19.5 %) 29/41 (70.7%) 4/41 (9.8%) 
 
 
1.2 Gestational Age: 








The majority of patients, about 45.9% who ruptured membranes during the late 
preterm period, were found to be between 36+0 to 36+6 weeks of gestation. There 
were 27% of patients in each of the gestation age groups, between 34+0 to 34+6 weeks 


















Table 3.4: Comparison of Gestational Age & Latency period 
 
GESTATIONAL 




LATENCY PERIOD   
< 48 HOURS 
(n=81) 
LATENCY PERIOD 
≥ 48 HOURS 
(n=41) 
p value 
34+0 – 34+6 
 
21/81(25.9%) 12/41(29.3%) 0.69 
35+0 – 35+6 
 
16/81(19.8%) 17/41(41.4%) 0.01 
36+0 - 36+6 
 
44/81(54.3%) 12/41(29.3%) 0.01 
 
 
The latency period was compared in the 3 different gestational age groups. Between 
34+0 to 34+6 weeks of gestation, 25.9% patients were in the shorter latency group as 
compared to 29.3% in the longer latency group. This was not statistically significant. 
However, in the gestational age group of 36+0 to 36+6 weeks, 54.3% of patients had a 
latency period of less than 48 hours compared to 29.3% with a latency period of 
greater or equal to 48 hours and this was statistically significant suggesting that the 
greater the gestational age, the shorter was the duration between the time of rupture 
of membranes and time of delivery. 
 
1.3 Obstetric risk factors: 
 
The obstetric risk factors consisted of the booking details of the patient, any history 
of previous caesarean section, the administration of antenatal corticosteroids and any 
medical comorbidities that can affect the management of patients with preterm 







3.31 Booking Details: 
 
Table 3.5: Representation of booking details of patients with PPROM 
 
BOOKING FREQUENCY (n%) 
BOOKED + ANC 114(93.4) 
BOOKED NO ANC 1(0.8) 
UNBOOKED 7(5.7) 
 
There was 93.4% of patients booked, with regular antenatal care follow up either at 
their respective Midwife Obstetric Units or the two secondary level hospitals. Only 
one patient was found to default antenatal care while 5.7% were unbooked. 
 
3.32 Previous caesarean section: 
 About 9.8% of the patients in the study had only one previous caesarean section and 
these patients were included in the study. These patients were admitted to the 
antenatal ward awaiting spontaneous labour. If they were undelivered after 24 hours, 
they had a caesarean section as per protocol. 
 
Figure 3.3: Patients with Previous caesarean section
 








Table 3.6: Representation of Obstetric risk factors 
  




12 (9.8%) 110 (90.2%) 
ANTENATAL STEROIDS 23 (18.8%) 99 (81.2%) 
MEDICAL COMORBIDITIES 7 (5.7%) 115 (94.3%) 
 
 
3.33 Antenatal Corticosteroids: 
 
Antenatal corticosteroids are usually given prior to 34 weeks of gestation. However, 
in the study, it was found that 18.8% of patients had received corticosteroids either 
before 34 weeks of gestation due to preterm labour or it was given when the 
gestational age was close to 34 weeks.  
 
3.34 Medical Comorbidities: 
 
Medical comorbidities can alter the course of the index pregnancy and also affect the 
timing of delivery. In the study, 5.7% of patients were found to have associated 
medical complications which either were present prior to pregnancy such as 
Hypertension or Bronchial Asthma or developed during the course of pregnancy 
such as Impaired Glucose Tolerance(IGT). It should be noted that patients with other 
medical comorbidities such as Diabetes Mellitus, cardiac or neurological patients 
were not included in the study as they are managed at a tertiary hospital namely 
Groote Schuur Hospital in the Metro West Obstetric Service in the Western Cape. It 
should also be noted that all patients in the study were HIV negative. HIV positive 
patients were considered as an exclusion criteria after review of the original protocol 
of the study by the HREC (Human Subjects Research Ethics Committee) of the 








LATENCY PERIOD   
< 48 HOURS 
(n=81) 
LATENCY PERIOD 






9/81(11.1%) 3/41(7.3%) 0.506 
MEDICAL 
COMORBIDITIES 
3/81(3.7%) 4/41(9.8%) 0.174 
ANTENATAL 
STEROIDS 
15/81(18.5%) 8/41(19.5%) 0.895 
 
 
When the obstetric risk factors were analysed between the two groups of patients, 
there was no statistical differences noted in terms of previous caesarean section, 
medical comorbidities and the use of antenatal corticosteroids. 
 












Smoking is considered to be a major risk factor in patients with Preterm prelabour 
Rupture of membranes. Of all women in the study, 42% were smokers with 37 
patients in the short latency group and 18 patients in the long latency group. The 
majority of them were in the coloured ethnic group. About 58% of patients were 
non-smokers. 
 
3.42: Use of Antibiotics: 
 












NONE 0 0 0 26 26(21.3) 
ORAL 
ANTIBIOTICS 
16 1 1 0 18(14.8) 
IV 
ANTIBIOTICS 
0 74 2 2 78(63.9) 
 
In the study, antibiotics were given during the first 24 hours and intrapartum as 
recommended by the Guidelines for Maternity Care in South Africa 3rd edition 2007 
and the updated guidelines 4th edition 201511. Twenty-six patients did not receive 
antibiotics and 18 patients received oral antibiotics mainly Azithromycin. Seventy-
eight patients received intravenous antibiotics mainly Ampicillin. Two of them 
received both Ampicillin and Metronidazole and 2 of them were unspecified. 
 
Table 3.9: Use of Antibiotics and Latency Period 
 
 LATENCY PERIOD 
< 48 HOURS 
(n=81) 
LATENCY PERIOD 
≥ 48 HOURS 
(n=41) 
p value 
NO ANTIBIOTICS 24/81(29.6%) 2/41(4.9%) 0.002 
ORAL 
ANTIBIOTICS 
11/81(13.6%) 7/41(17.1%) 0.607 
IV ANTIBIOTICS 46/81(56.8%) 32/41(78.0%) 0.021 
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Fifty-six percent of the patients in the short latency period and 78% of patients in the 
long latency period required IV antibiotics. The difference between the proportions 
was statistically significant (p value= 0.021). In the short latency period, 29.6% of 
patients received no antibiotics and 4.9% in the longer latency period did not receive 
antibiotics. This finding is consistent with there being need for antibiotics when 
delivery is imminent and this finding was statistically significant (p = 0.002). 
Antibiotics were prescribed in accordance with the recommendations in the 
Guidelines for Maternity Care in South Africa. 
 
 
3.5 Neonatal Outcomes: 
 
The neonatal outcomes were divided into primary and secondary outcomes. Primary 
outcomes included both composite neonatal infectious morbidity and composite 
neonatal prematurity morbidity.  
 
Table 3.10: Representation of secondary Neonatal outcomes 
 
APGAR SCORE TOTAL (n=122) 
1 MINUTE 5 MINUTES 
NORMAL 116/122(95.1%) 121/122(99.2%)  
LOW 2/122(1.6%) 0 
CRITICAL 1/122(0.8%) 1(0.8%) 
HIGH CARE ADMISSION (n=122)  
METABOLIC COMPLICATIONS 11/122(9.0%) 
 
RESPIRATORY COMPLICATIONS 2/122(1.6%) 
 
NOT ADMITTED 109/122(89.3%) 
 
LENGTH OF NEONATAL STAY (Days) 
TOTAL (n=121) 
 






Table 3.11: Comparison of Neonatal Outcomes between the two latency periods 
 
	
 LATENCY PERIOD   < 
48 HOURS 
(n=81) 





NEONATAL SEPSIS 1/81(1.2%) 0 






BIRTHWEIGHT 2569(329.4) 2432(289.3) 
APGAR SCORE < 4 AT 5 
MINUTES 
1/81(1.2%) 0 
ADMISSION TO HIGH CARE 
 




NEONATAL STAY > 7 DAYS 0 1/41(2.4%) 
 
*one neonatal folder had missing information(n=80) 
 
3.51 Neonatal Infectious Morbidity: 
 
Neonatal infectious morbidity was defined as any one of the following: 
• A diagnosis of sepsis (A positive blood or CSF culture with an identified 
organism) 
• Pneumonia 
• Necrotising enterocolitis  
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The clinical signs of neonatal sepsis included respiratory distress, apnoea, lethargy, 
abnormal level of consciousness, circulatory compromise needing support, poor 
feeding and/or temperature instability. 
 
Any preterm baby delivered in a woman with Prelabour rupture of membranes of 
more than 18 hours was empirically started on Intravenous ceftriaxone for a 
minimum of 2 to 3 days and a Full blood count along with Blood culture and CRP 
were done as part of the protocols at both secondary level hospitals. 
 
In our study, only one neonate was found to have neonatal sepsis in the short latency 
group. This was based on a positive blood culture and a high CRP. 
 
There were no neonatal deaths in the study. 
 
3.52 Neonatal Prematurity Morbidity: 
 
Neonatal prematurity morbidity was defined as a diagnosis of any one of moderate or 
severe Respiratory distress syndrome, bronchopulmonary dysplasia, intraventricular 
haemorrhage, periventricular leukomalacia or retinopathy of prematurity. There were 
2 cases of respiratory distress syndrome that were admitted to high care and these 
accounted for 1.6% of the neonatal prematurity complications. There were no cases of 
bronchopulmonary dysplasia, intraventricular haemorrhage, periventricular 
leukomalacia and retinopathy of prematurity as these complications are rare after 34 
weeks of gestation. 
 
3.53 Secondary Neonatal Complications: 
 
This included Apgar scores at one and five minute intervals, birth weight, metabolic 
complications (hypoglycaemia, hyperbilurubinaemia), NICU admission and length 








There were 95.1% and 99.2% of neonates who had normal Apgar scores, that is 7 out 
of 10 at 1 minute and 5 minutes after birth respectively. In the whole of the study 





Nine percent of the neonates had metabolic complications such as hypoglycaemia 
and hyperbilirubinemia which were most common. One folder was missing from our 
records. 
 
Admission to NICU/HIGH CARE: 
 
Table 3.12: Comparison of Metabolic complications between Latency period 
 
 
 METABOLIC COMPLICATIONS 
PRESENT ABSENT 









*one neonatal folder had missing information (n=80) 
 
 
Table 3.13: Comparison of Respiratory complications between Latency period 
 
 RESPIRATORY COMPLICATIONS 
PRESENT ABSENT 













Thirteen neonates were admitted to high care out of which 2 had respiratory 
complications one in the short latency period and one in the long latency period. 
Eleven of them had metabolic complications. There was no statistical difference 
between the two groups in terms of metabolic complications. About 89.3% of the 
neonates were allowed to be transferred to their mothers and all of them were 
considered to be well enough to stay in the postnatal ward. They were all given 
intravenous ceftriaxone empirically. 
 
Duration of Neonatal stay:  
 
Only one neonate stayed in high care for more than 7 days and that was related to 
metabolic complication. (The denominator was n = 121 for this factor as one 























3.6 Maternal Outcomes: 
 
The maternal outcomes were divided into a primary composite infectious maternal 
morbidity and secondary maternal outcomes. 
 
3.61 Composite Maternal Infectious Outcomes: 
 
Composite maternal infectious outcome was defined as a diagnosis of any puerperal 
sepsis which included endometritis, septicaemia, peritonitis or wound infection. 
 
Table 3.14: Representation of Maternal Infectious Outcomes 
 
 
 TOTAL (n=122) 




CHORIOAMNIONITIS 1 0.82 
INTRAPARTUM PYREXIA 1 0.82 








PUERPERAL SEPSIS 0 0 
 
There were no cases of composite infectious maternal morbidity such as 
endometritis, septicaemia, peritonitis or wound infection. However, one case of 
chorioamnionitis was noted that required triple antibiotics intrapartum. Only 12 
patients were given intravenous antibiotics postpartum and all of them had a 
caesarean section. All the patients were discharged home on oral antibiotics namely 




3.62 Secondary Maternal Outcomes: 
 
The secondary maternal outcomes were grouped into antepartum, intrapartum and 
postpartum outcomes. 
 
1. Antepartum and Intrapartum Outcomes were: 
Intrapartum pyrexia, chorioamnionitis, antepartum haemorrhage, 
spontaneous onset of labour, use of augmentation of labour, mode of 
delivery and failed induction requiring caesarean delivery. 
2. Postpartum outcomes were 
Puerperal sepsis, hysterectomy, requirement of antibiotics and length 
of hospital stay.  
3.63 Labour and Delivery: 
 
Table 3.15: Representation of Secondary Maternal Outcomes 
 
OUTCOME TOTAL (n=122) 
SPONTANEOUS ONSET OF LABOUR 42/122 (34.4%) 
 
INDUCTION OF LABOUR 80/122 (65.6%) 
 
AUGMENTATION OF LABOUR 17/122 (13.9%) 
 
FAILED INDUCTION OF LABOUR 12/122 (9.8%) 
 
VAGINAL DELIVERY 92/122 (75.4%) 
 
CAESAREAN SECTION 30/122 (24.6%) 
 
ANTEPARTUM HAEMORRHAGE 2/122 (1.6%) 
 




About 34.4% of women with Prelabour rupture of membranes had spontaneous onset 
of labour before 24 hours while 80 women out 122 were induced after 24 hours. 
During labour, 13.9% required augmentation with intravenous oxytocin while 12 of 
them had a failed Induction of labour and needed an operative delivery. 
 
Mode of Delivery: 
Table 3.16: Mode of Delivery 
 
MODE OF DELIVERY TOTAL (n=122) 
FREQUENCY (n) PERCENTAGE(n%) 
VAGINAL DELIVERY 92 75.4 
CESAREAN DELIVERY 30 24.6 
 
Ninety-two women in the study had a normal vaginal delivery. Thirty women 
(24.6%) had a caesarean section and the indications were mostly failed induction of 
labour which constituted 9.8%. Other indications for caesarean section were failed 
VBAC and fetal distress. 
 
Table 3.17: Comparison of Labour characteristics and Latency period 
 
 LATENCY 













36/81(44.4%) 6/41(14.6%) 3.0(1.4-6.6) 0.001 
INDUCTION OF 
LABOUR 
45/81(55.6%) 35/41(85.4%) 0.7(0.5-0.8) 0.001 
AUGMENTATION 
OF LABOUR 
7/81(8.6%) 10/41(24.4%) 0.4(0.2-0.9) 0.018 
VAGINAL 
DELIVERY 
58/81(71.6%) 34/41(82.9%) 0.8(0.7-1.1) 0.170 
CAESAREAN 
DELIVERY 
23/81(28.4%) 7/41(17.1%) 1.6(0.8-3.5) 0.170 
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Women in the short latency period were more likely to have a spontaneous onset of 
labour. This finding was statistically significant.  
 
About 55.6% of women in the short latency period had an induction of labour after 
24 hours out of which 71.6% had a normal vaginal delivery and 28.4% had a 
caesarean section. Compared to women who were induced in the long latency period, 
82.9% delivered vaginally and 17.1% had a caesarean section. This latter finding was 
not statistically significant. 
 
3.64 Secondary Maternal Complications: 
 
There were 2 reported cases of antepartum haemorrhage. There was one 
hysterectomy as a result of postpartum haemorrhage.  
 
Table 3.18: Secondary Antepartum complications during IOL in late PPROM 
 
 TOTAL (n=122) 



















3.7 Comparison of Composite Maternal and Neonatal Outcomes at different 
Gestational Age Groups: 
 











ABSENT PRESENT ABSENT PRESENT 
34+0 – 34+6 33(100) 0 28(84.6) 5(15.2) 
35+0 – 35+6 32(97.0) 1(3.0) 26(78.8) 7(21.2) 
36+0 – 36+6 54(96.4) 2(2.5) 51(91.1) 5(8.9) 
TOTAL 119(97.5) 3(2.5) 105(86.1) 17(13.9) 
P value 0.56 0.26 
  
The composite maternal and neonatal outcomes were analysed at different 
gestational ages in the late preterm population. There were more maternal outcomes 
(13.9%) compared to the neonatal outcomes (2.5%) during the study.  
 
There were no complications in 97.5% of the neonates born between 34+0 to 36+6 
weeks of gestation in pregnant women who had prelabour rupture of membranes. Of 
the 2.5% of neonates who were affected, there was one case of neonatal sepsis and 
two cases of respiratory complications, namely respiratory distress syndrome. The p 
value when neonatal outcomes were compared to the gestational age was 0.56 and 
was not statistically significant. About 13.9% of the pregnant women in the study 
had an adverse maternal outcome between this specific gestational age of 34+0 to 
36+6 weeks. The p value when maternal outcomes were compared to gestational age 






3.8 Comparison of Composite Maternal and Neonatal Outcomes between the 
two latency periods: 
 
Table 3.20: Comparison of Composite Neonatal Outcomes between the two 
latency periods 
 
LATENCY PERIOD COMPOSITE NEONATAL OUTCOMES n(%) 
PRESENT ABSENT 
LESS THAN 48 
HOURS 
2(2.5) 79(97.5) 
MORE THAN OR 
EQUAL TO 48 HOURS 
                1(2.4) 40(97.6) 
TOTAL  3(2.5) 119(97.5) 
P value 0.99 
 
 




LATENCY PERIOD COMPOSITE MATERNAL OUTCOMES n(%) 
PRESENT ABSENT 
LESS THAN 48 
HOURS 
14(17.3) 67(82.7)) 
MORE THAN OR 
EQUAL TO 48 HOURS 
3(7.3) 38(92.7)3(7.3) 
TOTAL 17(13.9) 105(86.1) 
P value 0.13 
 
 
The effect of latency period was analysed with respect to maternal and neonatal 
outcomes. The risk of having an adverse neonatal outcome between the two latency 
periods was negligible and the p value was 0.99 which was statistically not 
significant. 
 
There were more secondary maternal outcomes in the short latency period, that is 
latency period before 48 hours which might have been related to failed induction of 
labour leading to caesarean section. This finding is possibly also an indication that 
the pregnancy was not prolonged in patients who developed or were at risk of 
adverse outcomes. The p value between the 2 groups was 0.13 which was not 
statistically significant. 
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3.9 Comparison of Maternal and Neonatal Outcomes in both Latency Periods: 
 
Table 3.22: Comparison of Outcomes with Latency period 
 
 LATENCY 













NEONATAL SEPSIS 1/81(1.2%) 0 N/A N/A 





1/81(1.2%) 1/41(2.4%) 0.5(0.03-7.89) 0.62 
BIRTHWEIGHT 2569(329.4) 2432(289.3)   
APGAR SCORE <4 AT 
5 MINUTES 
1/81(1.2%) 0 N/A N/A 












NEONATAL STAY > 
7 DAYS 
0 1/41(2.4%) N/A N/A 




1/81(1.2%) 0 N/A N/A 
INTRAPARTUM 
FEVER 
1/81(1.2%) 0 N/A N/A 
CHORIOAMNIONITIS 1/81(1.2%) 0 N/A N/A 
HYSTERECTOMY 1/81(1.2%) 0 N/A N/A 
POST PARTUM 
ANTIBIOTICS 




5/81(6.2%) 1/41(2.4%) 2.5(0.31-21.0) 0.37 
 
 
* N/A: The relative risk is not reported when there was no events in any of 





The primary outcome of neonatal sepsis occurred in only one neonate which was in 
the short latency period and there was none in the longer latency period. There were 
no statistical differences between the composite neonatal prematurity complications, 
critical Apgar scores at 5 minutes, admission to high care unit as a result of 
metabolic or respiratory complications and the duration of neonatal stay in hospital 
between the two groups. 
When the secondary maternal outcomes were analysed, there was only one case of 
antepartum haemorrhage, intrapartum pyrexia and chorioamnionitis which was in the 
short latency period compared to none in the longer latency period and this was not 
statistically significant. 
There was also one case of hysterectomy which was related to postpartum 
haemorrhage and was also not statistically significant. 
About 12.3% of women in the shorter latency period required postpartum antibiotics 
compared to 4.9% in the longer latency period and this was also not statistically 
significant (p=0.190). 
 
There was no statistical difference between the length of maternal hospitalization 


















3.10 Comparison of Birth weight and Latency period: 
 
Table 3.23: Distribution of Birth weight and Latency period 
 




95 % CI 
Short Latency 
(< 48 hours) 
80 2543.6 46.9 419.7 2450.2-
2637.1 
Long Latency 
(≥ 48 hours) 
41 2423.6 45.2 289.3 2332.3-
2514.9 
P value 0.10 
 
 
This table represents t-test for the distribution of birth weight between the two 
groups, short latency period (< 48 hours) and long latency period (≥ 48 hours). There 
were 80 patients in the short latency group and 41 patients in the long latency group. 
The p value was 0.10, i.e there was no statistical differences between the mean birth 


















Summary of Results of the study: 
 
There were 122 patients in the study of maternal and neonatal outcomes in late 
preterm prelabour rupture of membranes between two different latency periods. All 
of the patients were HIV negative. The short latency period was defined as the time 
from the rupture of membranes until birth and was less than 48 hours. The long 
latency period was considered if there was more than 48 hours between rupture of 
membranes and time of delivery. 
 
• There was no statistical difference in the means and distribution of maternal 
ages between the two groups. 
 
• In patients who were between 34+0 to 34+6 weeks of gestation, the proportion 
of patients between the short and long latency groups was the same. Between 
35+0 to 35+6 weeks, there was a difference in proportion of patients between 
the two groups of latency period. This is an unusual finding and is probably 
related to an inadequate sample size of our study. However, between 36+0 to 
36+6 weeks of gestation, there was a difference in the proportion of patients 
between the short and long latency period and more was in the former. This 
finding explained that the further the gestational age is closer to term, the 
more likely the patients were to be induced and hence a shorter latency 
period. 
 
• In terms of obstetric risk factors which included a history of previous 
caesarean section, medical comorbidities and the use of antenatal 
corticosteroids, no statistical difference was noted between the two groups. 
 
• There was no statistical difference in patients who required antibiotics in both 
groups. 
 
• There was no statistical difference noted in terms of both maternal and 
neonatal outcomes when they were compared in both groups. 
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• There was no statistical difference noted in when maternal and neonatal 
outcomes at different gestational age groups were compared. It was noted 




• There was no statistical difference when the mean birth weight was compared 



























CHAPTER 4: DISCUSSION 
 
The study was carried out on patients who presented with late preterm prelabour 
rupture of membranes by dividing the patients between two groups according to the 
latency period. The first group was that of short latency which was less than 48 hours 
and the second was the long latency period group which was 48 hours or more. 
 
Most major published studies addressing the clinical question of immediate induction 
versus expectant management of patients with late preterm PPROM include patients 
who are delivered only for obstetric reasons or once they reach 37 completed weeks 
gestation. This was not the case in our study where the decision to deliver was either 
taken based on the National Maternity Guideline or clinician preference. Another 
possible reason for this discrepancy is that our study was not a randomised trial. We 
believe that this is a limitation of our study. 
 
Based on the result of this study of pregnant women who had ruptured membranes 
between 34+0 to 36+6 weeks of gestation, expectant management was safe with 
reduced risk of adverse neonatal outcomes. It was also noted that the latency period 
was even shorter as the gestational age was close to term. This finding is not 
surprising as most clinicians would deliver at or close to 37 completed weeks of 
gestation. 
 
It was initially anticipated that there will be a higher rate of composite maternal and 
neonatal infectious morbidity in the study population. However, we found only one 
case of neonatal sepsis and this was seen in a patient who had an early induction of 
labour. It was also noted that there were no cases of maternal sepsis in either of the 
two groups. Thus, there was no difference between the two groups (short versus long 
latency period) in terms of maternal and neonatal infectious morbidity outcome. 
 
It was also hypothesized that there will be more composite prematurity 
complications when delivery would have occurred in the early latency period. 
However, no significant differences were found between the two groups. This is 
probably because the maximum latency period in this study was not more than 96 
hours. This was a limitation in the study as compared to the PPROMT trial since the 
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current standard of care recommended in South Africa is to induce labour within 12 
to 24 hours after rupture of membranes above 34 weeks of gestation. Since this study 
was carried out in low risk patients and excluding HIV patients, it is probable that 
expectant management would have decreased prematurity complications if the 
latency period was defined as that of the PPROMPT trial. 
 
There were more adverse maternal outcomes noted in the study compared to neonatal 
outcomes. This was related mostly to the mode of delivery and it was noted that 
patients in the early delivery group had a higher incidence of operative delivery.  
About 24.6% of women in the study had a caesarean section and the incidence was 
higher in those patients who had a latency period within 48 hours (28.4%) compared 
to those whose latency period was more than 48 hours (17.1%). It was mostly as a 
result of failed induction of labour or due to fetal distress associated with 
augmentation of labour. Hence it can be concluded that early induction in patients 
with ruptured membranes in the late preterm period was associated with more 
intervention and an increased likelihood of caesarean section. 
 
The PPROMT trial showed that antepartum haemorrhage was one of the main 
adverse maternal outcomes in patients who were in the expectant management group. 
There were no cases of antepartum haemorrhage noted in our study. This was 
probably because the latency period was not long as in the PPROMT trial and hence 
patients were delivered early. It can be concluded that if expectant management is to 
be observed, then the increased risk of antepartum haemorrhage needs to be taken 
into consideration and patients need close monitoring.  
 
The study by Mercer et al17 after randomising 93 patients with ruptured membranes 
and documented lung maturity between 32 to 36 weeks of gestation concluded that 
expectant management was associated with prolonged maternal and neonatal 
hospitalisation along with an increase incidence of chorioamnionitis and the 
requirement of antibiotics. Similarly, another study by Naef et al18 among patients 
with PPROM between 34 to 37 weeks of gestation also reported a higher incidence 
of chorioamnionitis and increased duration of maternal and neonatal stay in hospital. 
When both studies were taken together, they both supported immediate induction as 
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compared to delayed induction of labour. However, they do not provide guidance 
regarding the timing of induction when compared to the neonatal outcomes. 
 
Expectant management is associated with higher chances of spontaneous onset of 
labour and allowing adaptive changes to occur in the neonate resulting in less 
neonatal prematurity complications mostly respiratory distress. As a result, more 
neonates will be of older gestation and hence fewer will require admission to nursery 
or high care. This will also allow more bonding between mothers and neonates, as 
well as improving the rate of breast feeding which is of utmost importance on the 
African continent where many neonates are at risk of adverse childhood outcomes. 
 
The findings of the largest trial carried out to date on late preterm prelabour rupture 
of membranes, the PPROMT trial, clearly favours expectant management. The 
adoption of such a practice in our setting, at level 2 hospitals, with careful 
monitoring of both the mother and the fetus such as monitoring for fever or other 
signs of chorioamnionitis and antepartum haemorrhage can decrease maternal and 
neonatal adverse outcomes. One of the drawbacks of expectant management in these 
low risk pregnant women will be an impact on the economy of the health care system 
in view of longer maternal admission. However, spending more money on maternal 
admission is more acceptable than using resources on the management of adverse 
neonatal complications in ICU or a neonatal high care which is much more 














CHAPTER 5: CONCLUSION 
 
This retrospective observational study was carried out in low risk HIV negative 
women with singleton pregnancies with ruptured membranes in the late preterm 
period. It has been shown that there were no significant differences in both maternal 
and neonatal outcomes between the two groups of latency periods when latency was 
defined as the time from ruptured membranes to delivery. Hence prioritising a 
delayed induction of labour in low risk HIV negative patients with careful maternal 
and fetal monitoring can be beneficial to the newborn babies as well as to the health 
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APPENDIX 1:DATA COLLECTION SHEET LATE PPROM STUDY  
STUDY NUMBER   
FOLDER NUMBER   
AGE    
GRAVIDITY   
PARITY   






1= Positive on Rx              3=Negative 
 2=Positive not on Rx       4=Unknown 
  






1=Black                       3=White 
2=Coloured                4=Others 
  
SMOKER  
1=Yes     2=No 
  
PREVIOUS C/S  
1=Yes     2=No 
  
MEDICAL COMORBIDITIES  
1=Yes     2=No 
  
BOOKING 
1= Booked + ANC 
2= Booked but no ANC 
3= Unbooked 
  
USE OF ANTIBIOTICS 
1=None 




TYPE OF ANTIBIOTICS USED 
1=Azithromycin            4= None 
2=Penicillin 
3=Penicillin and Flagyl 
  
ANTENATAL CORTICOSTEROIDS 
1=Yes        2= No 
  
LATENCY PERIOD 
1= <24 hours          3= 48 hours- 7 days 




COMPOSITE NEONATAL INFECTIOUS MORBIDITY 
NEONATAL SEPSIS 
 1=Yes         2=No 
  
PNEUMONIA 
 1=Yes         2=No 
  
NECROTISING ENTEROCOLITIS 
1=Yes          2=No 
  
NEONATAL DEATH 
1=Yes          2=No 
  
COMPOSITE NEONATAL PREMATURITY MORBIDITY 
 
RESPIRATORY DISTRESS SYNDROME 
1=Yes          2=No 
  
BRONCHOPULMONARY DYSPLASIA 




1=Yes          2=No 
  
PERIVENTRICULAR LEUKOMALACIA 
1=Yes      2=No 
  
RETINOPATHY OF PREMATURITY 




COMPOSITE MATERNALINFECTIOUS MORBIDITY 
 
ENDOMETRITIS 
 1=Yes         2=No 
  
SEPTICAEMIA 
 1=Yes         2=No 
  
PERITONITIS 
1=Yes          2=No 
  
WOUND INFECTION 








 1=Yes         2=No 
  
CHORIOAMNIONITIS 
 1=Yes         2=No 
  
ANTEPARTUM HEMORRHAGE 
1=Yes          2=No 
  
TRIPLE ANTIBIOTICS INTRAPARTUM 
1=Yes          2=No 
  
SPONTANEOUS ONSET OF LABOUR 
1=Yes          2=No 
  
AUGMENTATION OF LABOUR 
1=Yes          2=No 
  
VAGINAL DELIVERY 
1=Yes          2=No 
  
FAILED INDUCTION 
1=Yes          2=No 
  
CAESAREAN DELIVERY 
1=Yes          2=No 
  
PUERPERAL SEPSIS 
1=Yes          2=No 
  
HYSTERECTOMY 
1=Yes          2=No 
  
POSTPARTUM INTRAVENOUS ANTIBIOTICS 
1=Yes          2=No 
  
LENGTH OF MATERNAL HOSPITALISATION 





APGAR SCORE 1 MINUTE   
APGAR SCORE 5 MINUTES   
BIRTH WEIGHT 
1= ≤ 2 Kg        2= > 2 kg 
  
METABOLIC COMPLICATIONS 
1=Yes      2=No 
  
ADMISSION TO NICU 
 1=Yes   2=No 
  
LENGTH OF NICU ADMISSION 




APPENDIX 2:  Data Collection Sheet (Definition of components) 
1. Chorioamnionitis11: 
It is defined as the acute inflammation of the fetal membranes and chorion of 
the placenta, typically due to ascending polymicrobial bacterial infection in the 
setting of membrane rupture. When clinical signs are present, the condition is 
referred to as clinical chorioamnionitis. It is characterised by the following: 
• Fever (Temperature > 38⁰C) 
• Maternal tachycardia (Pulse ≥ 100 beats/minute) 
• Fetal tachycardia (FHR ≥ 160 beats/minute) 
• Uterine fundal tenderness/ Irritability 
• Offensive smell of liquor 
Leucocytosis and raised CRP for the diagnosis or prediction of 
chorioamnionitis as part of routine clinical practice is not established as it is 
common during labour and with the use of steroids. 
2.  Apgar Score: 
The test is generally done at one and five minutes after birth, and may be 
repeated later if the score is and remains low. Scores 7 and above are generally 
normal, 4 to 6 fairly low, and 3 and below are generally regarded as critically 
low. 
Components of Apgar score are listed as follows: 
 
SCORE 0 1 2 
APPEARANCE Complete 
cyanosis 





PULSE absent < 100/min >100/min 










RESPIRATION absent Weak,irregular,gasping Strong,lusty cry 
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3. Latency Period: 
It is defined from the time of rupture of membranes to the time of delivery of 
the baby. 
 
4. Use of Antibiotics11: 
In our setting, once the woman is induced she is given a stat dose of 2 gm of 
Ampicillin followed by 1 gm 6 hourly. If the patient is allergic to penicillin, 
she is given Clindamycin 600 mg 8 hourly. 
In case of chorioamnionitis, triple antibiotics with Ampicillin, Gentamycin and 
flagyl are administered. 
 
5. Neonatal Infectious Morbidity25: 
Neonatal sepsis: 
 
This is defined as signs and symptoms of infection and a positive culture of a 
known pathogen from blood or cerebrospinal fluid. The clinical signs of 
infection include respiratory distress, apnoea, lethargy, abnormal level of 





The disease is characterised by various degrees of mucosal or transmural 
necrosis of the intestine as a result of intestinal immaturity. The first signs of 
impending disease may be nonspecific, including lethargy and temperature 
instability, or related to gastrointestinal pathology, such as abdominal 






6. Secondary Neonatal Outcomes25: 
Respiratory Distress Syndrome: 
 
It is also known as hyaline membrane disease and its incidence is inversely 
related to the gestational age and birth weight. It occurs as a result of 
surfactant deficiency and has a 15-30% incidence between 32-36 weeks of 
gestation. It is usually characterised by tachypnoea, grunting, intercostal and 
subcostal recession and nasal flaring. Its definitive diagnosis is by a Chest   





This is a pathological process which leads to chronic lung disease in the 
neonatal period. The current accepted definition involves oxygen requirement 
for 28 days or more postnatally. It is typically characterised by tachypnoea, 
mouth breathing due to narrowed air passages and high arched palate. 
 
Intraventricular Haemorrhage and Periventricular Leukomalacia: 
 
When intracranial haemorrhage involves the ventricles, it is known as 
intraventricular haemorrhage (IVH). Venous obstruction as a result of IVH 
will result in decreased perfusion leading to necrosis and focal necrotic areas 
in the brain is known as periventricular leukomalacia (PVL). Both conditions 
are very common in premature infants because of immature blood vessels in 
the region of the developing brain combined with poor tissue vascular 
support. Neurological manifestations will be seen shortly after birth and in 
case of PVL, it is usually asymptomatic until the neurological sequelae of 






Retinopathy of Prematurity: 
 
Usually detected late in infancy, it occurs as a result of injury to the retinal 
angiogenesis process which starts early in prenatal life from the region of the 
optic disc and proceeds to the periphery around 36-40 weeks of gestation. 
 
7. Composite Maternal Infectious Morbidity:26 
 
This was defined as any postpartum patient who presented with puerperal 
pyrexia with a temperature above 38⁰ C on any two days of the first ten days 
of puerperium, exclusive of the first 24 hours. Patients who presented with 
wound infection post caesarean section, endomyometritis, pelvic abscess and 
peritonitis after prolonged rupture of membranes were included under this 
outcome variable. 
 
Endomyometritis has an incidence in excess of 30% in patients in patients with 
prolonged rupture of membranes after a caesarean section. The above 4 
conditions will usually manifest with fever, abdominal pain, offensive lochia, 















APPENDIX 3:  HREC APPROVAL LETTER 
 
 
 
 
	
